FDA Issues Updated Guidance on Generic Drug Bioequivalence Studies Top News May 22, 2026 Regulators clarify study design and data requirements for ANDA submissions, with implications for manufacturers planning 2026 filings.
WHO Panel Urges Stronger Global Surveillance of Novel Biologics Top News May 22, 2026 Health agencies push harmonized reporting standards as cross-border biologic shipments accelerate.
China Revises GMP Inspection Rules for Exported Finished Dosage Forms Top News May 21, 2026 Updated inspection framework targets facilities supplying oral solid forms to regulated markets.
UK MHRA Expands Fast-Track Pathway for Critical Generic Shortages Top News May 21, 2026 Temporary supply authorizations could shorten timelines when hospitals report stock gaps.